Online Store

Biosimilars are a multi-billion dollar market that has brought up litigation around the world. While the FDA has just recently approved a biosimilar Remicade, Europe has seen the same product, along with many other biosimilars, in the market for several years now. In this webinar, we will cover patent and regulatory aspects of several European biosimilars, what effect they have on the US, and what can we learn from their experience.  Presented by:  Gareth Morgan of Olswang, LLP; Holger Tostmann of Wallinger Ricker Schlotter Tostmann; and moderated by Carla Mouta of Finnegan Henderson Farabow Garrett & Dunner, LLP.